| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 7.04e-09 | 11 | 140 | 5 | GO:0101020 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 3.00e-08 | 14 | 140 | 5 | GO:0008401 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 1.22e-07 | 34 | 140 | 6 | GO:0008395 | |
| GeneOntologyMolecularFunction | heme binding | TPO CYP3A7 CYP2C19 CYP2C9 CYP3A4 CYP3A5 ADGB DUOX1 FECH CYP2U1 | 1.35e-07 | 154 | 140 | 10 | GO:0020037 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 1.59e-07 | 8 | 140 | 4 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 1.59e-07 | 8 | 140 | 4 | GO:0034875 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | TPO CYP3A7 CYP2C19 CYP2C9 CYP3A4 CYP3A5 ADGB DUOX1 FECH CYP2U1 | 2.43e-07 | 164 | 140 | 10 | GO:0046906 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.16e-06 | 49 | 140 | 6 | GO:0016712 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 2.98e-06 | 15 | 140 | 4 | GO:0016725 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 3.34e-06 | 5 | 140 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | aromatase activity | 4.32e-06 | 35 | 140 | 5 | GO:0070330 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | DOCK1 RAPGEF6 TRIO RGL3 OBSCN DENND4C RGL1 ARHGEF40 ARHGEF3 FGD3 | 5.46e-06 | 231 | 140 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | oxygen binding | 5.74e-06 | 37 | 140 | 5 | GO:0019825 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 1.84e-05 | 8 | 140 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 3.58e-05 | 27 | 140 | 4 | GO:0004709 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 4.88e-05 | 2 | 140 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 4.88e-05 | 2 | 140 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 4.88e-05 | 2 | 140 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 4.88e-05 | 2 | 140 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 WNK2 | 5.16e-05 | 363 | 140 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.60e-04 | 115 | 140 | 6 | GO:0004497 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.72e-04 | 166 | 140 | 7 | GO:0005506 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK1 RAPGEF6 TRIO RGL3 OBSCN DENND4C RGL1 ARHGEF40 TBC1D14 ARHGEF3 ARHGAP27 FGD3 | 2.43e-04 | 507 | 140 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK1 RAPGEF6 TRIO RGL3 OBSCN DENND4C RGL1 ARHGEF40 TBC1D14 ARHGEF3 ARHGAP27 FGD3 | 2.43e-04 | 507 | 140 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 2.90e-04 | 4 | 140 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 2.90e-04 | 4 | 140 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 2.90e-04 | 4 | 140 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 WNK2 | 3.13e-04 | 446 | 140 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 4.44e-04 | 194 | 140 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 4.81e-04 | 5 | 140 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 4.81e-04 | 5 | 140 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 4.81e-04 | 5 | 140 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 4.81e-04 | 5 | 140 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 4.81e-04 | 5 | 140 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 7.19e-04 | 6 | 140 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 7.19e-04 | 6 | 140 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 1.00e-03 | 7 | 140 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | protein kinase activity | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 FGFR3 WNK2 | 1.08e-03 | 600 | 140 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.12e-03 | 10 | 140 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 3.08e-03 | 12 | 140 | 2 | GO:0004706 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 9.38e-07 | 12 | 139 | 4 | GO:0070989 | |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 5.90e-06 | 6 | 139 | 3 | GO:0016098 | |
| GeneOntologyBiologicalProcess | demethylation | 1.89e-05 | 24 | 139 | 4 | GO:0070988 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 2.44e-05 | 9 | 139 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.61e-05 | 52 | 139 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 3.07e-05 | 180 | 139 | 8 | GO:0120254 | |
| GeneOntologyBiologicalProcess | myoblast fusion | 4.45e-05 | 58 | 139 | 5 | GO:0007520 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.03e-04 | 14 | 139 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.10e-04 | 37 | 139 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.42e-04 | 286 | 139 | 9 | GO:0042445 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | CYP3A7 CYP2C19 CYP2C9 CYP3A4 CYP3A5 PPP1R12A CFTR MBD1 ABCC6 NEUROD1 FECH CYP2U1 | 2.33e-04 | 525 | 139 | 12 | GO:0009410 |
| GeneOntologyBiologicalProcess | steroid metabolic process | CYP3A7 CYP2C19 CYP2C9 CYP3A4 CYP3A5 DHRS11 CFTR FECH NR0B1 CACNA1H | 2.39e-04 | 376 | 139 | 10 | GO:0008202 |
| GeneOntologyBiologicalProcess | transepithelial water transport | 2.68e-04 | 4 | 139 | 2 | GO:0035377 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.75e-04 | 85 | 139 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.75e-04 | 85 | 139 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DOCK1 RAPGEF6 TRIO RGL3 OBSCN DENND4C RASIP1 RGL1 ARHGEF40 ARHGEF3 ARHGAP27 FGD3 | 2.91e-04 | 538 | 139 | 12 | GO:0007264 |
| GeneOntologyBiologicalProcess | syncytium formation | 3.41e-04 | 89 | 139 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level chemical homeostasis | 3.59e-04 | 90 | 139 | 5 | GO:0140962 | |
| Domain | Cyt_P450_CS | 2.52e-06 | 53 | 138 | 6 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 3.88e-06 | 57 | 138 | 6 | PS00086 | |
| Domain | Cyt_P450_E_grp-II | 3.90e-06 | 5 | 138 | 3 | IPR002402 | |
| Domain | p450 | 4.31e-06 | 58 | 138 | 6 | PF00067 | |
| Domain | Cyt_P450 | 5.26e-06 | 60 | 138 | 6 | IPR001128 | |
| Domain | Cyt_P450_E_CYP3A | 7.77e-06 | 6 | 138 | 3 | IPR008072 | |
| Domain | Cyt_P450_E_grp-I | 1.97e-05 | 45 | 138 | 5 | IPR002401 | |
| Domain | fn3 | 2.75e-05 | 162 | 138 | 8 | PF00041 | |
| Domain | - | 6.85e-05 | 58 | 138 | 5 | 1.10.630.10 | |
| Domain | Ser/Thr_kinase_AS | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 WNK2 | 7.05e-05 | 357 | 138 | 11 | IPR008271 |
| Domain | FN3 | 7.06e-05 | 185 | 138 | 8 | SM00060 | |
| Domain | S_TKc | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 WNK2 | 7.41e-05 | 359 | 138 | 11 | SM00220 |
| Domain | RA | 7.69e-05 | 31 | 138 | 4 | SM00314 | |
| Domain | PROTEIN_KINASE_ST | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 WNK2 | 7.98e-05 | 362 | 138 | 11 | PS00108 |
| Domain | Ig_I-set | 8.51e-05 | 190 | 138 | 8 | IPR013098 | |
| Domain | I-set | 8.51e-05 | 190 | 138 | 8 | PF07679 | |
| Domain | FN3 | 1.17e-04 | 199 | 138 | 8 | PS50853 | |
| Domain | Pkinase | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 WNK2 | 1.25e-04 | 381 | 138 | 11 | PF00069 |
| Domain | RA | 1.40e-04 | 36 | 138 | 4 | PF00788 | |
| Domain | RA | 1.56e-04 | 37 | 138 | 4 | PS50200 | |
| Domain | PROTEIN_KINASE_ATP | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 FGFR3 WNK2 | 1.56e-04 | 459 | 138 | 12 | PS00107 |
| Domain | PRKG1_interact | 1.62e-04 | 3 | 138 | 2 | IPR031775 | |
| Domain | PRKG1_interact | 1.62e-04 | 3 | 138 | 2 | PF15898 | |
| Domain | MYPT1/MYPT2_chordates | 1.62e-04 | 3 | 138 | 2 | IPR017401 | |
| Domain | DUF4071 | 1.62e-04 | 3 | 138 | 2 | PF13281 | |
| Domain | DUF4071 | 1.62e-04 | 3 | 138 | 2 | IPR025136 | |
| Domain | FN3_dom | 1.65e-04 | 209 | 138 | 8 | IPR003961 | |
| Domain | RhoGEF | 1.69e-04 | 70 | 138 | 5 | PF00621 | |
| Domain | DH_2 | 1.69e-04 | 70 | 138 | 5 | PS50010 | |
| Domain | - | 1.80e-04 | 71 | 138 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 1.80e-04 | 71 | 138 | 5 | IPR000219 | |
| Domain | RA_dom | 2.12e-04 | 40 | 138 | 4 | IPR000159 | |
| Domain | PH | TRIO PHLDA1 OBSCN CDC42BPB ARHGEF40 ARHGEF3 ARHGAP27 PLEKHO1 FGD3 | 2.27e-04 | 278 | 138 | 9 | SM00233 |
| Domain | PH_DOMAIN | TRIO PHLDA1 OBSCN CDC42BPB ARHGEF40 ARHGEF3 ARHGAP27 PLEKHO1 FGD3 | 2.33e-04 | 279 | 138 | 9 | PS50003 |
| Domain | PH_domain | TRIO PHLDA1 OBSCN CDC42BPB ARHGEF40 ARHGEF3 ARHGAP27 PLEKHO1 FGD3 | 2.39e-04 | 280 | 138 | 9 | IPR001849 |
| Domain | Prot_kinase_dom | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 FGFR3 WNK2 | 2.79e-04 | 489 | 138 | 12 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 FGFR3 WNK2 | 3.01e-04 | 493 | 138 | 12 | PS50011 |
| Domain | Neurogenic_DUF | 3.22e-04 | 4 | 138 | 2 | IPR022575 | |
| Domain | Neuro_bHLH | 3.22e-04 | 4 | 138 | 2 | PF12533 | |
| Domain | TF_bHLH_NeuroD | 3.22e-04 | 4 | 138 | 2 | IPR016637 | |
| Domain | IGc2 | 3.64e-04 | 235 | 138 | 8 | SM00408 | |
| Domain | Ig_sub2 | 3.64e-04 | 235 | 138 | 8 | IPR003598 | |
| Domain | RasGEFN | 4.10e-04 | 20 | 138 | 3 | SM00229 | |
| Domain | RasGEF_N | 4.76e-04 | 21 | 138 | 3 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 5.48e-04 | 22 | 138 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 5.48e-04 | 22 | 138 | 3 | PS50212 | |
| Domain | - | TRIO PHLDA1 OBSCN CDC42BPB ARHGEF40 MTMR3 ARHGEF3 ARHGAP27 PLEKHO1 FGD3 | 6.62e-04 | 391 | 138 | 10 | 2.30.29.30 |
| Domain | Kinase-like_dom | TRIO MARK1 MAP3K14 OBSCN LRRK1 MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 FGFR3 WNK2 | 6.99e-04 | 542 | 138 | 12 | IPR011009 |
| Domain | IG | TRIO OBSCN MPIG6B PTGFRN DSCAML1 CNTN6 NEO1 CNTN3 FGFR3 VCAM1 | 1.16e-03 | 421 | 138 | 10 | SM00409 |
| Domain | Ig_sub | TRIO OBSCN MPIG6B PTGFRN DSCAML1 CNTN6 NEO1 CNTN3 FGFR3 VCAM1 | 1.16e-03 | 421 | 138 | 10 | IPR003599 |
| Domain | DH_1 | 1.21e-03 | 63 | 138 | 4 | PS00741 | |
| Domain | RASGEF_CAT | 1.25e-03 | 29 | 138 | 3 | PS50009 | |
| Domain | PH_dom-like | TRIO PHLDA1 OBSCN CDC42BPB ARHGEF40 MTMR3 ARHGEF3 ARHGAP27 PLEKHO1 FGD3 | 1.27e-03 | 426 | 138 | 10 | IPR011993 |
| Domain | RasGEF | 1.38e-03 | 30 | 138 | 3 | PF00617 | |
| Domain | - | 1.38e-03 | 30 | 138 | 3 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 1.38e-03 | 30 | 138 | 3 | IPR001895 | |
| Domain | RasGEF | 1.38e-03 | 30 | 138 | 3 | SM00147 | |
| Domain | Ras_GEF_dom | 1.38e-03 | 30 | 138 | 3 | IPR023578 | |
| Domain | PH | 1.58e-03 | 229 | 138 | 7 | PF00169 | |
| Domain | RhoGEF | 1.61e-03 | 68 | 138 | 4 | SM00325 | |
| Domain | Protein_kinase_ATP_BS | MARK1 MAP3K14 OBSCN MAP3K6 CDC42BPB MAP3K5 TTBK1 MAP3K10 FGFR3 | 2.05e-03 | 379 | 138 | 9 | IPR017441 |
| Domain | IGv | 2.31e-03 | 75 | 138 | 4 | SM00406 | |
| Domain | An_peroxidase | 2.35e-03 | 10 | 138 | 2 | PF03098 | |
| Domain | Haem_peroxidase_animal | 2.35e-03 | 10 | 138 | 2 | IPR019791 | |
| Domain | Haem_peroxidase | 2.35e-03 | 10 | 138 | 2 | IPR010255 | |
| Domain | PEROXIDASE_3 | 2.35e-03 | 10 | 138 | 2 | PS50292 | |
| Domain | - | 2.35e-03 | 10 | 138 | 2 | 1.10.640.10 | |
| Domain | ig | 2.90e-03 | 190 | 138 | 6 | PF00047 | |
| Domain | Immunoglobulin | 2.90e-03 | 190 | 138 | 6 | IPR013151 | |
| Domain | GDS_CDC24_CS | 2.97e-03 | 39 | 138 | 3 | IPR001331 | |
| Domain | - | TRIO OBSCN VWA1 PTGFRN DSCAML1 CNTN6 FNDC1 NEO1 CNTN3 FGFR3 TNXB VCAM1 | 3.77e-03 | 663 | 138 | 12 | 2.60.40.10 |
| Domain | Ras_G-nucl-exch_fac_CS | 4.65e-03 | 14 | 138 | 2 | IPR019804 | |
| Domain | SH3 | 5.42e-03 | 216 | 138 | 6 | SM00326 | |
| Domain | SH3 | 5.42e-03 | 216 | 138 | 6 | PS50002 | |
| Domain | SH3_domain | 5.92e-03 | 220 | 138 | 6 | IPR001452 | |
| Domain | ATPase_P-typ_TM_dom | 6.08e-03 | 16 | 138 | 2 | IPR023298 | |
| Domain | - | 6.08e-03 | 16 | 138 | 2 | 1.20.1110.10 | |
| Domain | Ig-like_fold | TRIO OBSCN VWA1 PTGFRN DSCAML1 CNTN6 FNDC1 NEO1 CNTN3 FGFR3 TNXB VCAM1 | 6.16e-03 | 706 | 138 | 12 | IPR013783 |
| Domain | WD40_repeat_dom | 6.62e-03 | 297 | 138 | 7 | IPR017986 | |
| Domain | ATPase_P-typ_cation-transptr_C | 6.85e-03 | 17 | 138 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 6.85e-03 | 17 | 138 | 2 | PF00689 | |
| Pathway | REACTOME_XENOBIOTICS | 7.25e-07 | 23 | 108 | 5 | M5372 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 9.10e-07 | 24 | 108 | 5 | M46445 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 2.47e-06 | 29 | 108 | 5 | M2920 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 4.11e-06 | 32 | 108 | 5 | M39567 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 7.63e-06 | 62 | 108 | 6 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 9.19e-06 | 64 | 108 | 6 | M5650 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 1.76e-05 | 21 | 108 | 4 | M39631 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 3.55e-05 | 9 | 108 | 3 | M27143 | |
| Pathway | REACTOME_XENOBIOTICS | 3.64e-05 | 25 | 108 | 4 | MM14846 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 8.66e-05 | 59 | 108 | 5 | M11215 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 8.74e-05 | 31 | 108 | 4 | M39476 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 9.15e-05 | 12 | 108 | 3 | M48064 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 9.15e-05 | 12 | 108 | 3 | MM15616 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.28e-04 | 64 | 108 | 5 | M9488 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.45e-04 | 104 | 108 | 6 | M738 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.48e-04 | 66 | 108 | 5 | MM14839 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.86e-04 | 15 | 108 | 3 | MM15697 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.86e-04 | 15 | 108 | 3 | MM14965 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.96e-04 | 70 | 108 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.24e-04 | 72 | 108 | 5 | M9257 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 2.88e-04 | 76 | 108 | 5 | M19832 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.28e-04 | 18 | 108 | 3 | MM14843 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 3.49e-04 | 44 | 108 | 4 | M875 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.49e-04 | 44 | 108 | 4 | M45014 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 3.66e-04 | 80 | 108 | 5 | M800 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.81e-04 | 45 | 108 | 4 | MM15694 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 6.06e-04 | 22 | 108 | 3 | MM15614 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK1 TRIO CFTR OBSCN CDC42BPB ARHGEF40 LMAN1 WDR6 ARHGEF3 ARHGAP27 FGD3 | 6.61e-04 | 450 | 108 | 11 | M27078 |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 6.65e-04 | 52 | 108 | 4 | MM14743 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY | 8.55e-04 | 6 | 108 | 2 | M47680 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 8.55e-04 | 6 | 108 | 2 | M27909 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 8.86e-04 | 97 | 108 | 5 | M9400 | |
| Pathway | PID_P38_MKK3_6PATHWAY | 1.00e-03 | 26 | 108 | 3 | M20 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 TRIO CENPC PPP1R12A PPP1R12B CFTR OBSCN CDC42BPB ARHGEF40 LMAN1 WDR6 ARHGEF3 ARHGAP27 FGD3 | 1.17e-03 | 720 | 108 | 14 | M41838 |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.27e-03 | 105 | 108 | 5 | MM14842 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 TRIO CENPC PPP1R12A PPP1R12B CFTR OBSCN CDC42BPB LMAN1 WDR6 ARHGEF3 ARHGAP27 FGD3 | 1.36e-03 | 649 | 108 | 13 | MM15690 |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 1.38e-03 | 29 | 108 | 3 | M39676 | |
| Pathway | REACTOME_DRUG_ADME | 1.49e-03 | 109 | 108 | 5 | M45012 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.51e-03 | 220 | 108 | 7 | M10320 | |
| Pathway | BIOCARTA_ACETAMINOPHEN_PATHWAY | 1.58e-03 | 8 | 108 | 2 | MM1547 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 1.58e-03 | 8 | 108 | 2 | M27135 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.58e-03 | 8 | 108 | 2 | M27891 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK1 TRIO CFTR OBSCN CDC42BPB LMAN1 WDR6 ARHGEF3 ARHGAP27 FGD3 | 1.97e-03 | 439 | 108 | 10 | MM15595 |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 2.02e-03 | 9 | 108 | 2 | MM14833 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 2.02e-03 | 9 | 108 | 2 | MM15059 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 2.03e-03 | 70 | 108 | 4 | MM14824 | |
| Pathway | REACTOME_DRUG_ADME | 2.20e-03 | 119 | 108 | 5 | MM15692 | |
| Pubmed | 5.86e-11 | 8 | 142 | 5 | 20147896 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 18021343 | ||
| Pubmed | 2.66e-10 | 4 | 142 | 4 | 19337788 | ||
| Pubmed | CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. | 1.33e-09 | 5 | 142 | 4 | 20833683 | |
| Pubmed | 1.33e-09 | 5 | 142 | 4 | 18156313 | ||
| Pubmed | 3.97e-09 | 6 | 142 | 4 | 17900275 | ||
| Pubmed | 3.97e-09 | 6 | 142 | 4 | 19934793 | ||
| Pubmed | Induction and genetic regulation of mouse hepatic cytochrome P450 by cannabidiol. | 3.97e-09 | 6 | 142 | 4 | 8043019 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 TRIO OBSCN LRRK1 CDC42BPB KIAA2013 MAP3K5 SCAF1 ARHGEF40 CLN3 TMEM132A MTMR3 ANKRD34A CACNA1H CABIN1 ESPL1 ATP2A3 TRAPPC9 WNK2 IQCE HTT | 4.93e-09 | 1105 | 142 | 21 | 35748872 |
| Pubmed | 6.29e-09 | 17 | 142 | 5 | 19424794 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 1.56e-08 | 20 | 142 | 5 | 9890157 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPGEF6 TRIO PPP1R12A MBD1 MAP3K14 USP43 MPDZ MAP3K6 TRIP12 DNAH7 DENND4C RUSC2 KIAA1671 KCNQ5 MAP3K10 MPHOSPH9 PARD3 TRAPPC9 | 1.62e-08 | 861 | 142 | 18 | 36931259 |
| Pubmed | Identification and characterization of human FNBP3 gene in silico. | 1.84e-08 | 8 | 142 | 4 | 12964049 | |
| Pubmed | ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. | 1.84e-08 | 8 | 142 | 4 | 19593168 | |
| Pubmed | 3.30e-08 | 9 | 142 | 4 | 17178267 | ||
| Pubmed | 3.30e-08 | 9 | 142 | 4 | 19350405 | ||
| Pubmed | 3.30e-08 | 9 | 142 | 4 | 18496131 | ||
| Pubmed | 5.49e-08 | 10 | 142 | 4 | 18240903 | ||
| Pubmed | 5.49e-08 | 10 | 142 | 4 | 20235787 | ||
| Pubmed | 5.49e-08 | 10 | 142 | 4 | 12865317 | ||
| Pubmed | Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms. | 6.66e-08 | 3 | 142 | 3 | 17827141 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 19801957 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 20621111 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 31128914 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 20118548 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 18394438 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 23469989 | ||
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 6.66e-08 | 3 | 142 | 3 | 23143891 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 33866277 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 35081606 | ||
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 6.66e-08 | 3 | 142 | 3 | 20615193 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 37584614 | ||
| Pubmed | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 6.66e-08 | 3 | 142 | 3 | 32001245 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 32146629 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 37326083 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 17582393 | ||
| Pubmed | The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors. | 6.66e-08 | 3 | 142 | 3 | 21692828 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 34688813 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 8.60e-08 | 11 | 142 | 4 | 15469410 | |
| Pubmed | 8.60e-08 | 11 | 142 | 4 | 15039299 | ||
| Pubmed | 1.29e-07 | 12 | 142 | 4 | 15319333 | ||
| Pubmed | 1.39e-07 | 30 | 142 | 5 | 20529763 | ||
| Pubmed | 1.85e-07 | 13 | 142 | 4 | 16771603 | ||
| Pubmed | 1.85e-07 | 13 | 142 | 4 | 19696793 | ||
| Pubmed | Influence of ethnicity on pharmacogenetic variation in the Ghanaian population. | 1.85e-07 | 13 | 142 | 4 | 19546880 | |
| Pubmed | 2.58e-07 | 14 | 142 | 4 | 20970553 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 16924387 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 34689350 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 15248218 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 17635181 | ||
| Pubmed | Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients. | 2.66e-07 | 4 | 142 | 3 | 17922881 | |
| Pubmed | Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians. | 2.66e-07 | 4 | 142 | 3 | 24443221 | |
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 18978522 | ||
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 32279544 | ||
| Pubmed | Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2. | 2.66e-07 | 4 | 142 | 3 | 12881483 | |
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 3.51e-07 | 15 | 142 | 4 | 18855897 | |
| Pubmed | 4.41e-07 | 70 | 142 | 6 | 15128046 | ||
| Pubmed | 5.37e-07 | 233 | 142 | 9 | 37704626 | ||
| Pubmed | 6.08e-07 | 17 | 142 | 4 | 27197076 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 24168324 | ||
| Pubmed | Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample. | 6.62e-07 | 5 | 142 | 3 | 18382661 | |
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 6.62e-07 | 5 | 142 | 3 | 11266076 | |
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 19414633 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 17418993 | ||
| Pubmed | Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19. | 6.62e-07 | 5 | 142 | 3 | 16116487 | |
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 11093772 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 17047492 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 19106084 | ||
| Pubmed | Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study. | 6.62e-07 | 5 | 142 | 3 | 19926050 | |
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 12900870 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 14559847 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 20207952 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 18024866 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 21071160 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 25552922 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 19823875 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 16267764 | ||
| Pubmed | TRIO SYNE1 MBD1 FBXW4 SEC31A TRIP12 CDC42BPB DSCAML1 STAB1 CLIP4 RNF123 NEUROD2 MTMR3 MAP3K10 CERCAM ATP1A2 CABIN1 PADI2 RSBN1L | 1.31e-06 | 1285 | 142 | 19 | 35914814 | |
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 20179710 | ||
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 1.32e-06 | 6 | 142 | 3 | 17635176 | |
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 16401082 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 16595916 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 18231117 | ||
| Pubmed | 1.38e-06 | 193 | 142 | 8 | 19343046 | ||
| Pubmed | Perioperative genomic profiles using structure-specific oligonucleotide probes. | 2.22e-06 | 23 | 142 | 4 | 19474452 | |
| Pubmed | Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam. | 2.30e-06 | 7 | 142 | 3 | 18979093 | |
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 2.30e-06 | 7 | 142 | 3 | 11137287 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 19842932 | ||
| Pubmed | Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. | 2.30e-06 | 7 | 142 | 3 | 19219744 | |
| Pubmed | 2.98e-06 | 214 | 142 | 8 | 22199357 | ||
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 17502835 | ||
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 20430047 | ||
| Pubmed | Mapping the mouse dactylaplasia mutation, Dac, and a gene that controls its expression, mdac. | 3.68e-06 | 8 | 142 | 3 | 8666395 | |
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 18356043 | ||
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 18854779 | ||
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 20459744 | ||
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 19576320 | ||
| Pubmed | 4.35e-06 | 27 | 142 | 4 | 20173083 | ||
| Pubmed | 7.83e-06 | 10 | 142 | 3 | 19538885 | ||
| Pubmed | 7.83e-06 | 10 | 142 | 3 | 20602612 | ||
| Interaction | YWHAH interactions | RAPGEF6 TRIO MARK1 PPP1R12A CFTR USP43 FBXW4 MPDZ MAP3K6 TRIP12 DNAH7 DENND4C MAP3K5 RUSC2 KIAA1671 KCNQ5 MTMR3 MAP3K10 MPHOSPH9 PARD3 TRAPPC9 WNK2 HTT | 1.26e-06 | 1102 | 136 | 23 | int:YWHAH |
| Interaction | LCOR interactions | MTF2 OBSCN USP43 FBXW4 SEC31A TRIP12 RNF123 MAP3K10 CERCAM CABIN1 | 5.86e-06 | 242 | 136 | 10 | int:LCOR |
| Interaction | YWHAG interactions | RAPGEF6 MARK1 PPP1R12A CFTR MBD1 USP43 MPDZ MAP3K6 TRIP12 DNAH7 DENND4C MAP3K5 RUSC2 KIAA1671 TTBK1 KCNQ5 MTMR3 ANKRD34A MAP3K10 MPHOSPH9 PARD3 TRAPPC9 HTT | 9.95e-06 | 1248 | 136 | 23 | int:YWHAG |
| Cytoband | 10q24 | 1.76e-04 | 35 | 142 | 3 | 10q24 | |
| Cytoband | 7q21.1 | 2.63e-04 | 8 | 142 | 2 | 7q21.1 | |
| Cytoband | 6q25 | 6.14e-04 | 12 | 142 | 2 | 6q25 | |
| GeneFamily | Fibronectin type III domain containing | 1.70e-06 | 160 | 93 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.78e-06 | 161 | 93 | 8 | 593 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 6.44e-06 | 24 | 93 | 4 | 654 | |
| GeneFamily | Cytochrome P450 family 3 | 7.24e-06 | 8 | 93 | 3 | 1002 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.25e-05 | 66 | 93 | 5 | 722 | |
| GeneFamily | Cytochrome P450 family 2 | 7.65e-04 | 35 | 93 | 3 | 1001 | |
| GeneFamily | ATP binding cassette subfamily C | 1.97e-03 | 13 | 93 | 2 | 807 | |
| GeneFamily | WD repeat domain containing | 2.33e-03 | 262 | 93 | 6 | 362 | |
| GeneFamily | Immunoglobulin like domain containing | 3.20e-03 | 193 | 93 | 5 | 594 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 3.74e-06 | 20 | 142 | 4 | MM1104 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-08 | 162 | 142 | 8 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-06 | 112 | 142 | 6 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.64e-06 | 190 | 142 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_NE_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.73e-06 | 191 | 142 | 7 | f0a81f621e63e87ff62224b33cf0c71dfac1d6e2 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 193 | 142 | 7 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-06 | 194 | 142 | 7 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-06 | 194 | 142 | 7 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.02e-06 | 194 | 142 | 7 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-06 | 194 | 142 | 7 | ca1f24070424b44b7a442e4fca761ebfbe24b063 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-06 | 194 | 142 | 7 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 194 | 142 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-06 | 197 | 142 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 3.46e-06 | 198 | 142 | 7 | f540f464118edc0fb809ebcb813d0302e6952253 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 160 | 142 | 6 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | PBMC-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 1.26e-05 | 160 | 142 | 6 | 4dac64e58d9366c399f3d830848ccb720d400be7 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.51e-05 | 165 | 142 | 6 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-05 | 166 | 142 | 6 | 0590e404f45afce90e20f93f90a3def83949c66b | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.61e-05 | 167 | 142 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 168 | 142 | 6 | 17fb9426eeea407b26fb895b8397faca95b7552d | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 168 | 142 | 6 | a61b39884851384cffd430079040546d125b2b40 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 175 | 142 | 6 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 177 | 142 | 6 | 0d894a14ddbb2734557743e9efdb89cee5c26769 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-05 | 177 | 142 | 6 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-05 | 177 | 142 | 6 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-05 | 177 | 142 | 6 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-05 | 178 | 142 | 6 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 179 | 142 | 6 | 06f92c884189197c86793191c05f65e34925c097 | |
| ToppCell | frontal_cortex-Non-neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-05 | 179 | 142 | 6 | ef01478bd03eb00f0ff2b6a8ae9244687c5f85aa | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 2.46e-05 | 180 | 142 | 6 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.62e-05 | 182 | 142 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-05 | 182 | 142 | 6 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-05 | 183 | 142 | 6 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 184 | 142 | 6 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-05 | 184 | 142 | 6 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | Serous|World / shred by cell class for bronchial biopsy | 2.78e-05 | 184 | 142 | 6 | 09d0d1525c11dd326efd942684c03f79d992cf3b | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 184 | 142 | 6 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 185 | 142 | 6 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 185 | 142 | 6 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-05 | 186 | 142 | 6 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-05 | 186 | 142 | 6 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 187 | 142 | 6 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 3.14e-05 | 188 | 142 | 6 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 3.14e-05 | 188 | 142 | 6 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 189 | 142 | 6 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 189 | 142 | 6 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 189 | 142 | 6 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.33e-05 | 190 | 142 | 6 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.33e-05 | 190 | 142 | 6 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.43e-05 | 191 | 142 | 6 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-05 | 192 | 142 | 6 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 192 | 142 | 6 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.53e-05 | 192 | 142 | 6 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 3.53e-05 | 192 | 142 | 6 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.64e-05 | 193 | 142 | 6 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-05 | 193 | 142 | 6 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 193 | 142 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 193 | 142 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.64e-05 | 193 | 142 | 6 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-05 | 193 | 142 | 6 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.64e-05 | 193 | 142 | 6 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.64e-05 | 193 | 142 | 6 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | 95dfbd9d9b8a47801edcfc35fb0d685901dcd2f8 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | da926441053b499cb5107ccb116fb1b3844d82b7 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 3.74e-05 | 194 | 142 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | 2507f6dc7f1fe8b91fe1e24497d26d05afc3cd21 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | 54a7f693966b5c02f6b248950ddb5fa32af3ae67 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 194 | 142 | 6 | f34b3bbdebf56f66ff499e390e5515a4a4093f90 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-05 | 195 | 142 | 6 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.85e-05 | 195 | 142 | 6 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.85e-05 | 195 | 142 | 6 | 5f33ece997f074598b4201ff74f592ee07c86a06 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-05 | 195 | 142 | 6 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-05 | 195 | 142 | 6 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 196 | 142 | 6 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 197 | 142 | 6 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 197 | 142 | 6 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 4.08e-05 | 197 | 142 | 6 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 200 | 142 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-05 | 200 | 142 | 6 | 4fb6fd703aca9a992924245105ad99163146a415 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-05 | 200 | 142 | 6 | b50de1f8c8f598e281951e4587f2d96c11aac836 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-05 | 140 | 142 | 5 | ab90f6f30d89761687f8836e3d327d143ce49ed4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-04 | 145 | 142 | 5 | 186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 145 | 142 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 148 | 142 | 5 | fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 148 | 142 | 5 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 148 | 142 | 5 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-04 | 153 | 142 | 5 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-04 | 154 | 142 | 5 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-04 | 154 | 142 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-04 | 154 | 142 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Chat_(Habenular_cholinergic_cells)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.37e-04 | 82 | 142 | 4 | 51dd9ab3ddb26d3d3395d0c1a156a12a86caf89b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 155 | 142 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 155 | 142 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| Computational | Cytochrome P450. | 3.12e-06 | 14 | 83 | 4 | MODULE_106 | |
| Drug | propionanilide | 1.62e-08 | 14 | 141 | 5 | CID000012107 | |
| Drug | desmethyltrimipramine | 4.86e-08 | 7 | 141 | 4 | CID000160632 | |
| Drug | 16-O-demethylaconitine | 4.86e-08 | 7 | 141 | 4 | ctd:C486136 | |
| Drug | Voriconazole | 4.86e-08 | 7 | 141 | 4 | ctd:D065819 | |
| Drug | Azamulinum | 6.81e-08 | 18 | 141 | 5 | CID003086060 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 9.68e-08 | 8 | 141 | 4 | CID006439499 | |
| Drug | 11-HODE | 9.68e-08 | 8 | 141 | 4 | CID006438497 | |
| Drug | 4-hydroxyalprazolam | 9.68e-08 | 8 | 141 | 4 | CID000182017 | |
| Drug | AC1MHWVC | 1.73e-07 | 9 | 141 | 4 | CID003034089 | |
| Drug | phenylcyclopropane | 1.73e-07 | 9 | 141 | 4 | CID000070112 | |
| Drug | mono-N-demethyladinazolam | 2.33e-07 | 3 | 141 | 3 | ctd:C050132 | |
| Drug | Delavirdine | 2.33e-07 | 3 | 141 | 3 | ctd:D020008 | |
| Drug | Celsior | 2.88e-07 | 10 | 141 | 4 | ctd:C088453 | |
| Drug | 8-hydroxydaidzein | 2.88e-07 | 10 | 141 | 4 | CID005466139 | |
| Drug | 4-hydroxymidazolam | 2.88e-07 | 10 | 141 | 4 | CID000124449 | |
| Drug | AHMA | 2.88e-07 | 10 | 141 | 4 | CID000216240 | |
| Drug | Haloperidol metabolite I | 4.50e-07 | 11 | 141 | 4 | CID000038282 | |
| Drug | Ticalopride | 4.50e-07 | 11 | 141 | 4 | CID000216236 | |
| Drug | 1,4-naphthoquinone | 5.03e-07 | 26 | 141 | 5 | ctd:C035342 | |
| Drug | AC1Q5TZX | 5.69e-07 | 49 | 141 | 6 | CID000004547 | |
| Drug | fentichlor | 5.69e-07 | 49 | 141 | 6 | CID000007329 | |
| Drug | 5-hydroxydiclofenac | 6.71e-07 | 12 | 141 | 4 | CID003052566 | |
| Drug | 2-Tbmbfd | 6.71e-07 | 12 | 141 | 4 | CID000126928 | |
| Drug | 4-(N-propionylanilino)piperidine | 6.71e-07 | 12 | 141 | 4 | CID000259381 | |
| Drug | norclozapine | 6.71e-07 | 12 | 141 | 4 | ctd:C058272 | |
| Drug | efavirenz | 8.94e-07 | 29 | 141 | 5 | ctd:C098320 | |
| Drug | 1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea | 9.26e-07 | 4 | 141 | 3 | ctd:C558737 | |
| Drug | hydroxytrimipramine | 9.26e-07 | 4 | 141 | 3 | CID000160610 | |
| Drug | rabeprazole-thioether | 9.26e-07 | 4 | 141 | 3 | ctd:C523099 | |
| Drug | 5-methoxyflavone | 9.26e-07 | 4 | 141 | 3 | CID000094525 | |
| Drug | N-ethyl-3-toluamide | 9.26e-07 | 4 | 141 | 3 | ctd:C454678 | |
| Drug | AC1L18GM | 9.65e-07 | 13 | 141 | 4 | CID000000092 | |
| Drug | 1'-hydroxymidazolam | 9.65e-07 | 13 | 141 | 4 | CID000107917 | |
| Drug | clozapine N-oxide | 9.65e-07 | 13 | 141 | 4 | CID000036727 | |
| Drug | 5-hydroxyomeprazole | 9.65e-07 | 13 | 141 | 4 | CID000119560 | |
| Drug | quindine | CYP3A7 CYP2C19 CYP2C9 CYP3A4 CYP3A5 CFTR NUDT6 SLC22A8 ATP2A3 VCAM1 | 1.14e-06 | 219 | 141 | 10 | CID000001065 |
| Drug | hexobarbital | 1.28e-06 | 127 | 141 | 8 | CID000003608 | |
| Drug | carboxytolbutamide | 1.34e-06 | 14 | 141 | 4 | CID000159651 | |
| Drug | isocarbophos | 1.34e-06 | 14 | 141 | 4 | ctd:C549713 | |
| Drug | 7-BFC | 1.34e-06 | 14 | 141 | 4 | CID000848780 | |
| Drug | BP-7,8-oxide | 1.49e-06 | 32 | 141 | 5 | CID000037455 | |
| Drug | AC1L9XAW | 1.75e-06 | 33 | 141 | 5 | CID000477669 | |
| Drug | 1-naphthol | 1.75e-06 | 33 | 141 | 5 | ctd:C029350 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 1.82e-06 | 15 | 141 | 4 | ctd:C586542 | |
| Drug | 4-hydroxymephenytoin | 1.82e-06 | 15 | 141 | 4 | CID000119507 | |
| Drug | N-desethyloxybutynin | 1.82e-06 | 15 | 141 | 4 | CID000133577 | |
| Drug | benzimidazole | 1.83e-06 | 93 | 141 | 7 | CID000005798 | |
| Drug | desmethylsertraline | 2.04e-06 | 34 | 141 | 5 | CID000114743 | |
| Drug | 2-oxo-clopidogrel | 2.30e-06 | 5 | 141 | 3 | ctd:C540904 | |
| Drug | benfuracarb | 2.30e-06 | 5 | 141 | 3 | ctd:C096128 | |
| Drug | mono(2-ethyl-5-hydroxyhexyl) phthalate | 2.30e-06 | 5 | 141 | 3 | ctd:C479069 | |
| Drug | zonisamide | 2.34e-06 | 62 | 141 | 6 | CID000005734 | |
| Drug | pantoprazole | 2.37e-06 | 35 | 141 | 5 | CID000004679 | |
| Drug | 4-chromanol | 2.37e-06 | 35 | 141 | 5 | CID000092890 | |
| Drug | 6-hydroxychlorzoxazone | 2.42e-06 | 16 | 141 | 4 | CID000002734 | |
| Drug | desmethylazelastine | 2.42e-06 | 16 | 141 | 4 | CID000162558 | |
| Drug | TTMS | 2.42e-06 | 16 | 141 | 4 | CID000007215 | |
| Drug | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | 2.42e-06 | 16 | 141 | 4 | ctd:C495657 | |
| Drug | diosmetin | 3.15e-06 | 17 | 141 | 4 | ctd:C039602 | |
| Drug | noralfentanil | 3.15e-06 | 17 | 141 | 4 | CID000162172 | |
| Drug | 4-hydroxycyclophosphamide | 3.61e-06 | 38 | 141 | 5 | CID000099735 | |
| Drug | diazoxon | 3.61e-06 | 38 | 141 | 5 | CID000013754 | |
| Drug | propoxyphene | 3.71e-06 | 67 | 141 | 6 | CID000010100 | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.80e-06 | 196 | 141 | 9 | 4154_UP | |
| Drug | menthofuran | 4.03e-06 | 18 | 141 | 4 | CID000329983 | |
| Drug | 7-benzyloxyquinoline | 4.03e-06 | 18 | 141 | 4 | CID003035604 | |
| Drug | pleuromutilin | 4.03e-06 | 18 | 141 | 4 | CID000031326 | |
| Drug | Verapamil | 4.13e-06 | 105 | 141 | 7 | ctd:D014700 | |
| Drug | hydrocotarnine | 4.59e-06 | 6 | 141 | 3 | CID000003646 | |
| Drug | 3'-oxohexobarbital | 4.59e-06 | 6 | 141 | 3 | CID000160461 | |
| Drug | 4'-methoxyflavone | 4.59e-06 | 6 | 141 | 3 | CID000077793 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 4.59e-06 | 6 | 141 | 3 | ctd:C570106 | |
| Drug | avasimibe | 4.59e-06 | 6 | 141 | 3 | ctd:C423185 | |
| Drug | mono(2-ethyl-5-oxohexyl)phthalate | 4.59e-06 | 6 | 141 | 3 | ctd:C080276 | |
| Drug | AC1O5Z5L | 4.59e-06 | 6 | 141 | 3 | CID006443527 | |
| Drug | Alfentanil | 4.59e-06 | 6 | 141 | 3 | ctd:D015760 | |
| Drug | Cyclodextrins | 4.59e-06 | 6 | 141 | 3 | ctd:D003505 | |
| Drug | mepirodipine | 4.59e-06 | 6 | 141 | 3 | ctd:C050699 | |
| Drug | midazolam | 4.68e-06 | 107 | 141 | 7 | CID000004192 | |
| Drug | hydroxytolbutamide | 5.08e-06 | 19 | 141 | 4 | CID000003656 | |
| Drug | 6|A-Hydroxycortisol | 5.08e-06 | 19 | 141 | 4 | CID000150985 | |
| Drug | rabeprazole | 5.08e-06 | 19 | 141 | 4 | CID000005029 | |
| Drug | furafylline | 5.31e-06 | 41 | 141 | 5 | CID000003433 | |
| Drug | AC1L1IMA | 5.31e-06 | 41 | 141 | 5 | CID000004639 | |
| Drug | carteolol | 5.66e-06 | 72 | 141 | 6 | CID000002583 | |
| Drug | L 654969 | 6.00e-06 | 42 | 141 | 5 | CID000005218 | |
| Drug | N'-nitrosoanatabine | 6.32e-06 | 20 | 141 | 4 | CID000051291 | |
| Drug | 3C etc | 6.32e-06 | 20 | 141 | 4 | CID000164045 | |
| Drug | 3-methoxymorphinan | 6.32e-06 | 20 | 141 | 4 | CID000001671 | |
| Drug | sulfaphenazole | 7.59e-06 | 44 | 141 | 5 | CID000005335 | |
| Drug | polybrominated biphenyl | 7.59e-06 | 44 | 141 | 5 | CID000042948 | |
| Drug | AC1L21VM | 7.77e-06 | 21 | 141 | 4 | CID000039524 | |
| Drug | nirvanol | 7.77e-06 | 21 | 141 | 4 | CID000091480 | |
| Drug | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | 7.99e-06 | 7 | 141 | 3 | ctd:C547858 | |
| Drug | 3-MeO | 7.99e-06 | 7 | 141 | 3 | CID009574960 | |
| Drug | 4-(4-chlorobenzyl)pyridine | 7.99e-06 | 7 | 141 | 3 | CID000078124 | |
| Drug | 5-hydroxydiclofenac | 7.99e-06 | 7 | 141 | 3 | ctd:C117715 | |
| Drug | norfluoxetine | 7.99e-06 | 7 | 141 | 3 | ctd:C036139 | |
| Drug | quinidine-N-oxide | 7.99e-06 | 7 | 141 | 3 | CID000050979 | |
| Drug | 12-hydroxyellipticine | 7.99e-06 | 7 | 141 | 3 | ctd:C517214 | |
| Disease | tacrolimus measurement | 3.99e-07 | 4 | 138 | 3 | EFO_0008458 | |
| Disease | metabolonic lactone sulfate measurement | 1.68e-06 | 19 | 138 | 4 | EFO_0800659 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.17e-05 | 10 | 138 | 3 | EFO_0022090 | |
| Disease | Proton pump inhibitor response | 2.17e-05 | 2 | 138 | 2 | cv:CN297082 | |
| Disease | Esomeprazole response | 2.17e-05 | 2 | 138 | 2 | cv:CN077982 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 4.37e-05 | 15 | 138 | 3 | EFO_0800301 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 5.36e-05 | 16 | 138 | 3 | EFO_0800305 | |
| Disease | X-21258 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0800802 | |
| Disease | eosinophil count | RAPGEF6 MTF2 MAP3K14 SEC31A MPIG6B PTGFRN DNAH7 MAP3K5 NUP205 FNDC1 LMAN1 WDR6 TBC1D14 CACNA1H MPHOSPH9 ATP2A3 TNXB RSBN1L VCAM1 | 6.67e-05 | 1488 | 138 | 19 | EFO_0004842 |
| Disease | androsterone glucuronide measurement | 1.08e-04 | 20 | 138 | 3 | EFO_0800317 | |
| Disease | estrone conjugate measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0007971 | |
| Disease | Clozapine response | 1.29e-04 | 4 | 138 | 2 | cv:CN077971 | |
| Disease | estradiol measurement | 1.72e-04 | 110 | 138 | 5 | EFO_0004697 | |
| Disease | tauro-beta-muricholate measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0800569 | |
| Disease | Choledochal Cyst, Type I | 2.15e-04 | 5 | 138 | 2 | C0009439 | |
| Disease | Choledochal Cyst, Type II | 2.15e-04 | 5 | 138 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 2.15e-04 | 5 | 138 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 2.15e-04 | 5 | 138 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 2.15e-04 | 5 | 138 | 2 | C1257799 | |
| Disease | Choledochal Cyst | 2.15e-04 | 5 | 138 | 2 | C0008340 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 3.22e-04 | 6 | 138 | 2 | EFO_0021119 | |
| Disease | amphetamine abuse (implicated_via_orthology) | 3.22e-04 | 6 | 138 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 3.22e-04 | 6 | 138 | 2 | EFO_0800294 | |
| Disease | X-24574 measurement | 4.49e-04 | 7 | 138 | 2 | EFO_0800897 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 7.65e-04 | 9 | 138 | 2 | C0085548 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0800278 | |
| Disease | hyperglycemia (is_implicated_in) | 9.53e-04 | 10 | 138 | 2 | DOID:4195 (is_implicated_in) | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 9.53e-04 | 10 | 138 | 2 | EFO_0800289 | |
| Disease | beta-nerve growth factor measurement | 1.01e-03 | 42 | 138 | 3 | EFO_0008035 | |
| Disease | urinary metabolite measurement | 1.06e-03 | 245 | 138 | 6 | EFO_0005116 | |
| Disease | X-11308 measurement | 1.16e-03 | 11 | 138 | 2 | EFO_0800693 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.16e-03 | 11 | 138 | 2 | EFO_0801531 | |
| Disease | response to ondansetron, QT interval | 1.16e-03 | 11 | 138 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.16e-03 | 11 | 138 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 1.16e-03 | 11 | 138 | 2 | EFO_0800295 | |
| Disease | Intellectual Disability | 1.25e-03 | 447 | 138 | 8 | C3714756 | |
| Disease | thymol sulfate measurement | 1.39e-03 | 12 | 138 | 2 | EFO_0021170 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.39e-03 | 12 | 138 | 2 | EFO_0800291 | |
| Disease | cholestasis (biomarker_via_orthology) | 1.58e-03 | 49 | 138 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.64e-03 | 13 | 138 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 1.64e-03 | 13 | 138 | 2 | EFO_0800284 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 1.90e-03 | 14 | 138 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | X-21470 measurement | 1.90e-03 | 14 | 138 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.90e-03 | 14 | 138 | 2 | EFO_0800283 | |
| Disease | Metastatic melanoma | 2.09e-03 | 54 | 138 | 3 | C0278883 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 2.50e-03 | 16 | 138 | 2 | EFO_0020346 | |
| Disease | X-21410 measurement | 2.50e-03 | 16 | 138 | 2 | EFO_0800813 | |
| Disease | creatinine measurement | MAP3K14 OBSCN PIGU RASIP1 DUOX1 RNF123 ZZZ3 NRXN2 MTMR3 PARD3 RSBN1L UNC80 | 2.53e-03 | 995 | 138 | 12 | EFO_0004518 |
| Disease | fibrinogen measurement, factor VII measurement | 2.56e-03 | 58 | 138 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 3.16e-03 | 18 | 138 | 2 | EFO_0800288 | |
| Disease | hypertension | 3.30e-03 | 307 | 138 | 6 | EFO_0000537 | |
| Disease | etiocholanolone glucuronide measurement | 3.52e-03 | 19 | 138 | 2 | EFO_0800362 | |
| Disease | essential tremor | 3.88e-03 | 136 | 138 | 4 | EFO_0003108 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 3.90e-03 | 20 | 138 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | Cleft palate | 4.54e-03 | 71 | 138 | 3 | HP_0000175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLTRERGLLHSSKWS | 41 | Q9UJX2 | |
| TPELRGTWAAALSAR | 1116 | Q8TER5 | |
| AAPSSTKRRDSKLWS | 91 | Q9NR81 | |
| VTSLKGLWTLRAFGR | 1056 | P13569 | |
| WDSIPGRDSRSLALA | 676 | O94812 | |
| LTKLWRPTVGERLSR | 766 | Q5T601 | |
| AASRWKLRLIGSSAP | 1076 | Q8N7X0 | |
| WKRIRSLLSPTFTSG | 126 | P20815 | |
| SALSPGKSEDVVLRW | 516 | Q8NEB7 | |
| SGVWIDRSRPGSRKA | 416 | Q969M2 | |
| LAPRSSDLTDRVKVW | 231 | P29972 | |
| LQTKLLVSDSSRPGW | 186 | Q6NUN0 | |
| TPTSRWRDLEKAELS | 561 | Q8IYM0 | |
| KAALRRSWSSTPTAG | 601 | Q8N3C7 | |
| LAKIRDWGSGSDTLR | 546 | Q93084 | |
| WAEKVTSGGPLSRRN | 301 | Q69YU3 | |
| LSDSRKRTRTGRSWP | 476 | Q9Y483 | |
| QLAKLGRRWPSAASV | 31 | Q5U651 | |
| VPRTSLLKASWSSLR | 841 | Q5U651 | |
| TSLTLPRTAKRGCWS | 746 | Q9NZL6 | |
| PRKVASWRSLRTAGS | 51 | Q6IPM2 | |
| QSRRGKTWTLELSPE | 151 | Q92621 | |
| TKARAALGLSPITRW | 436 | Q9NRD9 | |
| LASGSRDKTVRIWVP | 76 | Q8NBT0 | |
| DSSSSILRWLPEKRA | 696 | Q8IYF1 | |
| GRTWGPSSTLQKERV | 556 | Q02779 | |
| APEEKAVTLRSLRSW | 751 | Q9BY89 | |
| LRRPRGLSSLWAAVS | 41 | O60721 | |
| ATIRTTKWELQRPAG | 671 | Q38SD2 | |
| DKTPLTWLGRLLSAG | 316 | Q9NR82 | |
| WKRLRSLLSPTFTSG | 126 | P08684 | |
| LHSSAPRSSWKERIL | 61 | Q9NVH0 | |
| LWNILEKPGSSTAAR | 196 | Q6PIU1 | |
| GTRFRDTAVWLPRSK | 581 | Q9UIS9 | |
| SSLLRSVWGPLKDNE | 731 | O95382 | |
| DSSTLTLWLREGPSR | 121 | P53370 | |
| CRWTRTGTKSTLPIS | 871 | P07202 | |
| LAQGRTARVTLTSPW | 146 | Q8N2G8 | |
| LPRWSAKRTGSISLD | 506 | Q9P2S2 | |
| TSDVSRRKWLIPGAE | 671 | Q99550 | |
| RVAPSLKSQRGSVWT | 81 | P49257 | |
| WGEATRSAKKPLRAS | 421 | Q8IXW0 | |
| RAVGLVSTWTQRSPL | 256 | Q5JSP0 | |
| SSSLGSRTLDPLWKV | 851 | Q9Y5S2 | |
| KQRWLLSPSTTLRVT | 66 | Q9Y2J8 | |
| SWRSSPGRIQSLKER | 51 | Q6NUT2 | |
| SWGAVSREPLSTFRK | 361 | Q3MIN7 | |
| SPLSSWKRVVEGLSL | 36 | Q9H490 | |
| GWRALTAPSTSARLR | 161 | Q8N4S7 | |
| WDTSSGALRPVALKS | 236 | P51843 | |
| AAVGRKRKWSSPSRS | 7381 | Q5VST9 | |
| LKSWDRAPTFLRELS | 7456 | Q5VST9 | |
| WSKDGAPLESSSRVL | 7496 | Q5VST9 | |
| IISTNLKIPSASGWR | 221 | Q8NGU1 | |
| WSGASALSPEALSKR | 116 | O95522 | |
| WLSSRTRAAGIDPSV | 86 | Q7Z449 | |
| SRLPWAARAGFKRTT | 141 | Q9NRJ2 | |
| KRSPTWTALSRIAGL | 411 | P50993 | |
| LKTLRDSLSGWDPET | 566 | Q14674 | |
| LLAASAPKSLRSSWA | 1096 | P42858 | |
| WLLTKGRSSAVSPRN | 556 | Q9Y6J0 | |
| LLSIWRQSSGRGKLP | 16 | P33261 | |
| VRWSSSGLPKDIDRL | 261 | Q14185 | |
| DSVLSSREALRKWPS | 191 | Q6ZN84 | |
| SREALRKWPSSVLAF | 196 | Q6ZN84 | |
| SFASRSWITIPRKAG | 311 | Q03188 | |
| LPADSRWTKRITGLT | 266 | Q8TD84 | |
| DRLSVAWKAPRLSGA | 171 | Q4ZHG4 | |
| RAFASSVTPDRKWLI | 1676 | Q8WXX0 | |
| GDTWKEASLLPLLSR | 226 | Q9H665 | |
| RLSRKLLWKPSGDFT | 646 | Q6NUI2 | |
| PSSTRSGIFLWTKVR | 871 | Q5VZ89 | |
| FPRAAISWKRGTETL | 436 | Q9UQ52 | |
| VSGSRDRTAKVWPLA | 216 | P57775 | |
| DRTAKVWPLASGRLG | 221 | P57775 | |
| EGKDSKPRSLRFTWS | 691 | Q9P0L2 | |
| LLSLWRQSSGRGKLP | 16 | P11712 | |
| WKRIRSLLSPTFTSG | 126 | P24462 | |
| GVLLRDPLASSSWRV | 16 | P22830 | |
| ADPKWELSRARLTLG | 461 | P22607 | |
| RLISWSGSQKTLRSP | 561 | Q5T4B2 | |
| RRSSWSSLGRAPSLK | 1141 | O95180 | |
| ARPDTLLSGSTSGWK | 101 | Q6UWP2 | |
| TPESIRWLVLSGKSS | 256 | Q8TCC7 | |
| EGLLSSSWPSATLKR | 41 | Q8N4B5 | |
| GAPKASTWVVASRRS | 6 | Q9NXZ2 | |
| WRRSDGLPFSSKIKL | 261 | Q9P232 | |
| KWAGSLRLGLTTLAP | 966 | Q96JN8 | |
| LESVSSFRSWKRIPA | 206 | Q13615 | |
| SRKNPTRWSTTAGFL | 166 | Q8TEW0 | |
| LAKTWAARGSRSREP | 356 | Q99558 | |
| RLSPRISATSKADIW | 1201 | A6NES4 | |
| SLSALLRSKWGPLKD | 761 | Q99683 | |
| PSSQILRKVSDSGWL | 131 | Q9NP80 | |
| SPVRGSLWREAATSL | 661 | Q9P2B2 | |
| PLGSWRSGLSRAESL | 856 | Q8N2Y8 | |
| TLPWGTLSSLKLQSR | 496 | Q6PCB5 | |
| FEGSLRRPLSWKSLA | 391 | Q8NCE0 | |
| SWRTQIDSPLSGKVR | 346 | P19320 | |
| SVARLRGTWEKLPSK | 961 | Q8TEU7 | |
| SLDWLRRVKAELSGP | 4896 | Q8NF91 | |
| PTLWTAKLDRFKGSR | 306 | Q24JP5 | |
| QPRKIGASSIARWIS | 186 | Q8NDG6 | |
| LRPKDLWSLGRENSS | 231 | O95255 | |
| ESKPGWISRSRSGIA | 61 | P57071 | |
| GGRLSLTWSVRLPRS | 121 | Q9NTG1 | |
| LSKGRRPILWASSSG | 56 | O95866 | |
| STRFIKLTWRTPASD | 451 | Q92859 | |
| LRGATLSWAPKDKSS | 561 | Q6ZUM4 | |
| SRVSTRWALPLDLSI | 371 | Q495M3 | |
| QWSLRPRGSLATFKT | 141 | Q7Z3Z2 | |
| STIRITPKDSRWVGA | 196 | G3V0H7 | |
| RASSLSRPWEKTDKG | 236 | Q53GL0 | |
| GKARSKSTRAPATTW | 171 | Q9P291 | |
| SKPGSSSSLSLRERW | 261 | Q13286 | |
| ARAKERWRSLSTGGS | 431 | Q9P2M4 | |
| RSLRVSWAPALGSAA | 346 | Q6PCB0 | |
| LRKPRITATIWSSGK | 51 | P62380 | |
| GSRLERDVWSAPSSL | 1056 | Q70EL4 | |
| GSLSAKERWSKRARP | 1071 | Q5TCY1 | |
| LPIGKRNWLKRSSLS | 1081 | Q8N2C7 | |
| RVELWREPSKSLGIS | 1151 | O75970 | |
| KRGLTPLARIVSWSQ | 271 | Q9BWD1 | |
| GPAARSSGTLWRIRT | 61 | Q8WV24 | |
| SLLPRLRAWRTGKTV | 146 | Q9H7N4 | |
| ESSKWRLRGQPTVLL | 301 | Q5XPI4 | |
| RALRGTSWGLPASKT | 821 | P22105 | |
| SNTTLLDAKVWRPLG | 196 | Q8IV45 | |
| QWLKSAGITLPADRR | 1006 | Q9NY15 | |
| SRPGTLKAVTLAGSW | 346 | Q9NNW5 | |
| VRLRGKEDPWNSITS | 81 | O60830 | |
| KGGPLRALSSKTWST | 341 | Q9H6Y2 | |
| WRIPSLKRSGEASVE | 986 | Q96Q05 | |
| RSWRPSKVDATQGRS | 781 | Q8NEE8 | |
| IRLWDPRTKDGSLVS | 321 | Q9GZL7 | |
| SGPVSVSIWSALKRL | 2101 | Q9Y3S1 | |
| SASPSGRATVWDLRK | 186 | O94979 | |
| WRSPAGARLRASLTL | 131 | Q53S58 | |
| FLASLNPKTWGRLST | 1041 | Q14669 | |
| TRESWVSPRKRGLSS | 76 | Q8IYH5 | |
| SGFALKDTWLRSLPR | 616 | Q9H091 | |
| WLTSPVRRLSSGKAD | 1776 | O75962 | |
| RLKGLPGLLSSSWAR | 6 | Q8IYS2 | |
| ESPATWRLGLRKTGS | 431 | O14974 | |
| KDESPSSWRLGLRKT | 431 | O60237 | |
| WALSEILRSGKSPDL | 151 | Q13562 | |
| WALSEILRSGKRPDL | 171 | Q15784 |